73294-1LORazepam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)Active
Part Descriptions
LP16176-7 LORazepam
Lorazepam (marketed under the brand names Ativan®, Temesta®, Tavor®) is a drug which is a benzodiazepine derivative. Pharmacologically, it is classified as a sedative -hypnotic, anxiolytic and anticonvulsant. Lorazepam reduces anxiety, interferes with new memory formation, reduces agitation, induces sleep, treats seizures, treats nausea and vomiting, and relaxes muscles. Lorazepam is used for the short-term treatment of anxiety, insomnia, acute seizures including status epilepticus, and sedation of hospitalized patients, as well as sedation of aggressive patients. Due to tolerance and dependence, lorazepam is recommended for short-term use, up to two to four weeks only. Among benzodiazepines, lorazepam has possible physical addiction potential. Lorazepam also has misuse potential; the main types of misuse are for recreational purposes.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Lorazepam (Wikipedia)
LP16176-7 LORazepam
A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: National Library of Medicine, MeSH 2006, Lorazepam (Wikipedia)
Fully-Specified Name
- Component
- LORazepam induced platelet Ab.IgM
- Property
- PrThr
- Time
- Pt
- System
- Ser/Plas
- Scale
- Ord
- Method
- Flow cytometry
Additional Names
- Short Name
- LORazepam ind plt IgM SerPl Ql FC
- Display Name
- LORazepam induced platelet IgM FC Ql
- Consumer Name Alpha
- LORazepam induced platelet IgM, Blood
Example Answer List LL360-9
Source: Regenstrief Institute
Answer | Code | Score | Answer ID |
---|---|---|---|
Positive Copyright http://snomed.info/sct ID:10828004 Positive (qualifier value) | LA6576-8 | ||
Negative Copyright http://snomed.info/sct ID:260385009 Negative (qualifier value) | LA6577-6 |
Basic Attributes
- Class
- SERO
- Type
- Laboratory
- First Released
- Version 2.44
- Last Updated
- Version 2.66
- Change Reason
- The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
72908-7 | Drug induced platelet Ab panel - Serum or Plasma |
Language Variants Get Info
- zh-CNChinese (China)
- 氯羟安定 诱导型血小板抗体.IgM:
存在情况或阈值: 时间点: 血清/血浆: 序数型: 流式细胞测量术 - nl-NLDutch (Netherlands)
- lorazepam geïnduceerd trombocyt As.IgM:
aanwezigheid: moment: serum of plasma: ordinaal: flowcytometrie - fr-FRFrench (France)
- Plaquettes anticorps IgM induits par lorazépam:
Présence/Seuil: Ponctuel: Sérum/Plasma: Qualitatif: Cytométrie de flux - it-ITItalian (Italy)
- Lorazepam Ab.IgM piastrine indotti da:
PrThr: Pt: Siero/Plasma: Ord: Citometria a flusso - pt-BRPortuguese (Brazil)
- Lorazepam plaquetas induzida Ac.IgM:
: Pt: Soro/Plas: Ord: Citometria de fluxo - ru-RURussian (Russian Federation)
- Лоразепам индуцированный пластинка Ат.IgM:
PrThr: ТчкВрм: Сыв/Плаз: Пор: Проточная цитометрия - es-MXSpanish (Mexico)
- Ab.IgM plaquetario inducido por LORazepam:
Presencia o umbral: Punto temporal: Suero o Plasma: Ordinal: Citometría de flujo (FC) - es-ESSpanish (Spain)
- Lorazepam Acs. IgM plaquetario inducido:
PrThr: Punto temporal: Suero o Plasma: Ord: Citometria de flujo (FC) - tr-TRTurkish (Turkey)
- Lorazepam uyarılmış trombosit Ab.IgM:
MevcEşik: Zmlı: Ser/Plaz: Srl: Akış sitometri
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=73294-1
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright